Bissell Brittany D, Campbell Jeannee, Collins Reagan, Cook Charles, Desai Dharati, DeWitt Jessica, Eche Ifeoma Mary, Eche Ijeoma Julie, Elsamadisi Pansy, Juul Janelle, Kim Soyoung, Makowski Courtney T, Mylvaganam Ruben J, Smith Adam, Stancati Jennifer, Stonesifer Katherine, Tawil Justin, Smith Condeni Melanie
University of Kentucky, Lexington, KY.
The University of Texas MD Anderson Cancer Center, Houston, TX.
Crit Care Explor. 2021 Dec 9;3(12):e0590. doi: 10.1097/CCE.0000000000000590. eCollection 2021 Dec.
To summarize selected meta-analyses and trials related to critical care pharmacotherapy published in 2020.
The Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update group screened 36 journals monthly for impactful publications.
The group reviewed a total of 119 articles during 2020 according to relevance for practice.
Articles were selected with consensus and importance to clinical practice from those included in the monthly Clinical Pharmacy and Pharmacology Pharmacotherapy Literature Update. The group reviewed articles according to Grading of Recommendations, Assessment, Development, and Evaluations criteria. Articles with a 1A grade were selected.
Several trials were summarized, including two meta-analyses and five original research trials. Original research trials evaluating vitamin C, hydrocortisone, and thiamine versus hydrocortisone in sepsis, the use of nonsedation strategies, dexmedetomidine in cardiac surgery, remdesivir for severe acute respiratory syndrome coronavirus 2, and thrombectomy in acute ischemic stroke. Two meta-analyses determining the impact of norepinephrine initiation in patients with septic shock and the use of corticosteroids in severe acute respiratory syndrome coronavirus 2 was included.
This clinical review provides summary and perspectives of clinical practice impact on influential critical care pharmacotherapy publications in 2020.
总结2020年发表的与重症监护药物治疗相关的部分荟萃分析和试验。
临床药学与药理学药物治疗文献更新小组每月筛选36种期刊,以获取有影响力的出版物。
该小组根据与实践的相关性,在2020年共审查了119篇文章。
从每月的《临床药学与药理学药物治疗文献更新》中纳入的文章中,根据共识和对临床实践的重要性选择文章。该小组根据推荐分级、评估、制定和评价标准对文章进行审查。选择1A级的文章。
总结了多项试验,包括两项荟萃分析和五项原始研究试验。原始研究试验评估了败血症中维生素C、氢化可的松和硫胺素与氢化可的松的对比、非镇静策略的使用、心脏手术中右美托咪定的使用、瑞德西韦治疗严重急性呼吸综合征冠状病毒2以及急性缺血性卒中的血栓切除术。纳入了两项荟萃分析,分别确定去甲肾上腺素起始对感染性休克患者的影响以及严重急性呼吸综合征冠状病毒2中皮质类固醇的使用。
本临床综述提供了2020年有影响力的重症监护药物治疗出版物对临床实践影响的总结和观点。